Skip to main content

Table 4 Course of disease regarding uveitis inactivity

From: Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study

 

Patients with uveitis documentation for ≥ 1 year

Patients with uveitis documentation at 5-year FU

 

n = 105

n = 75

Inactive uveitis at 5y-FU, n (%)

-

64 (85.3%)

Inactive on medication

 ≥ 6 months at 5y-FU, n (%)

-

41 (54.7%)

Inactive off medication

 ≥ 6 months at 5y-FU, n (%)

-

10 (13.3%)

Inactivity on medication ≥ 6 months, n (%)

85 (80.1%)

62 (82.7%)

Number phases of inactivity on medication ≥ 6 months during follow-up

 1, n (%)

42 (40.0%)

23 (30.7%)

 2, n (%)

31 (29.5%)

28 (37.3%)

 3, n (%)

10 (9.5%)

9 (12.0%)

 4, n (%)

2 (1.9%)

2 (2.7%)

Duration of inactivity on medication [months], mean (SD)

 1st phase

24.4 (18.9)

26.1 (20.9)

 2nd phase

20.8 (14.4)

21.6 (14.8)

 3rd phase

24.4 (16.2)

25.0 (16.8)

Inactivity off medication ≥ 6 months, n (%)

18 (17.1%)

13 (17.3%)

Number phases of inactivity off medication during follow-up

  

 1, n (%)

15 (14.3%)

10 (13.3%)

 2, n (%)

3 (2.9%)

3 (4.0%)

Duration of inactivity off medication [months], mean (SD)

 1st phase

26.5 (22.1)

29.5 (24.7)

 2nd phase

35.9 (12.3)

35.9 (12.3)

  1. Documentation of uveitis activity during five years of follow-up; inactive uveitis on medication for at least 6 months; inactive uveitis for at least 6 months off topical corticosteroids and systemic anti-inflammatory medication. 5y-FU: five years follow-up